{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:46:30Z","timestamp":1793832390452,"version":"4.6.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jneuroim.2022.577811","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T11:07:37Z","timestamp":1641812857000},"page":"577811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Up-regulated serum levels of TAM receptor tyrosine kinases in a group of Egyptian autistic children"],"prefix":"10.1016","volume":"364","author":[{"given":"Gehan Ahmed","family":"Mostafa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howida Hosny","family":"ElGebaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer Al Sayed","family":"Shehab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa Abd El Hamed","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2022.577811_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577811_bb0010","doi-asserted-by":"crossref","first-page":"132","DOI":"10.55563\/clinexprheumatol\/xyylza","article-title":"Increased plasma levels of Gas6 and its soluble tyrosine kinase receptors Mer and Axl are associated with immunological activity and severity of lupus nephritis","volume":"39","author":"Bellan","year":"2021","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jneuroim.2022.577811_bb0015","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1523\/JNEUROSCI.1180-08.2008","article-title":"Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination","volume":"28","author":"Binder","year":"2008","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577811_bb5000","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nn.3599","article-title":"Identification of a unique TGF-\u03b2-dependent molecular and functional signature in microglia","volume":"17","author":"Butovsky","year":"2014","journal-title":"Nat. Neurosci."},{"issue":"2019","key":"10.1016\/j.jneuroim.2022.577811_bb0020","first-page":"7838195","article-title":"Gas6\/TAM receptors in systemic lupus erythematosus","volume":"9","author":"Cohen","year":"2019","journal-title":"Dis. Markers"},{"key":"10.1016\/j.jneuroim.2022.577811_bb0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0074-7742(05)71013-8","article-title":"Immunological findings in autism","volume":"71","author":"Cohly","year":"2005","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.jneuroim.2022.577811_bb0030","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3389\/fncel.2018.00405","article-title":"Immune dysfunction and autoimmunity as pathological mechanisms in autism spectrum disorders","volume":"12","author":"Hughes","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jneuroim.2022.577811_bb0035","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.4049\/jimmunol.1302229","article-title":"TAM receptors affect adult brain neurogenesis by negative regulation of microglial cell activation","volume":"191","author":"Ji","year":"2013","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577811_bb0040","first-page":"1","article-title":"Anti-inflammatory role of TAM family of receptor tyrosine kinases via modulating macrophage function","volume":"42","author":"Lee","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jneuroim.2022.577811_bb0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1749-6632.2010.05744.x","article-title":"TAM receptors and the clearance of apoptotic cells","volume":"1209","author":"Lemke","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.jneuroim.2022.577811_bb0055","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1158\/2159-8290.CD-15-0933","article-title":"Reduced proteolytic shedding of receptor tyrosine kinases is a post-translational mechanism of kinase inhibitor resistance","volume":"6","author":"Miller","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jneuroim.2022.577811_bb0060","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1742-2094-8-180","article-title":"The possible link between the elevated serum levels of neurokinin A and anti-ribosomal P protein antibodies in children with autism","volume":"8","author":"Mostafa","year":"2011","journal-title":"J. Neuroinflammation"},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2022.577811_bb0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jneuroim.2013.04.003","article-title":"The possible relationship between allergic manifestations and elevated serum levels of brain specific auto-antibodies in autistic children","volume":"261","author":"Mostafa","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577811_bb0070","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12943-019-1022-2","article-title":"Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment","volume":"18","author":"Myers","year":"2019","journal-title":"Mol. Cancer"},{"issue":"36","key":"10.1016\/j.jneuroim.2022.577811_bb0075","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1146\/annurev-immunol-042617-053010","article-title":"Apoptosis and clearance of apoptotic cells","volume":"26","author":"Nagata","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577811_bb0080","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1172\/JCI58649","article-title":"Multiple sclerosis","volume":"122","author":"Nylander","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jneuroim.2022.577811_bb0085","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.clim.2016.05.011","article-title":"Heightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE","volume":"169","author":"Orme","year":"2016","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577811_bb0090","doi-asserted-by":"crossref","first-page":"1614627","DOI":"10.1155\/2020\/1614627","article-title":"New insights into the role of Tyro3, Axl, and Mer receptors in rheumatoid arthritis","volume":"2020","author":"Pagani","year":"2020","journal-title":"Dis. Markers"},{"issue":"10","key":"10.1016\/j.jneuroim.2022.577811_bb0095","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/cancers8100097","article-title":"The role of TAM family receptors in immune cell function: implications for cancer therapy","volume":"8","author":"Paolino","year":"2016","journal-title":"Cancers (Basel)."},{"issue":"49","key":"10.1016\/j.jneuroim.2022.577811_bb0100","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1038\/sj.onc.1203957","article-title":"The protein tyrosine kinase family of the human genome","volume":"19","author":"Robinson","year":"2000","journal-title":"Oncogene."},{"issue":"6","key":"10.1016\/j.jneuroim.2022.577811_bb0105","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cell.2007.10.034","article-title":"TAM receptors are pleiotropic inhibitors of the innate immune response","volume":"131","author":"Rothlin","year":"2007","journal-title":"Cell."},{"issue":"3","key":"10.1016\/j.jneuroim.2022.577811_bb0110","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood-2006-05-021634","article-title":"A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation","volume":"109","author":"Sather","year":"2007","journal-title":"Blood."},{"key":"10.1016\/j.jneuroim.2022.577811_bb0115","series-title":"The Childhood Autism Rating Scale (CARS) for Diagnostic Screening and Classification in Autism Irvington, New York","author":"Schopler","year":"1986"},{"key":"10.1016\/j.jneuroim.2022.577811_bb0120","doi-asserted-by":"crossref","first-page":"33335","DOI":"10.1074\/jbc.M111.263020","article-title":"Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase C\u03b4, and p38 mitogen-activated protein kinase (MAPK)","volume":"286","author":"Thorp","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577811_bb0125","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2353\/ajpath.2009.080807","article-title":"Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions","volume":"175","author":"Weinger","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2022.577811_bb0130","doi-asserted-by":"crossref","first-page":"4813795","DOI":"10.1155\/2019\/4813795","article-title":"Sjogren\u2019s syndrome and TAM receptors: a possible contribution to disease onset","volume":"2019","author":"Witas","year":"2019","journal-title":"J Immunol Res"},{"issue":"10","key":"10.1016\/j.jneuroim.2022.577811_bb0135","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3390\/cells7100166","article-title":"The dual role of TAM receptors in autoimmune diseases and cancer: an overview","volume":"7","author":"Wium","year":"2018","journal-title":"Cells."},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577811_bb0140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/cei.13082","article-title":"Soluble TAM receptor tyrosine kinases in rheumatoid arthritis: correlation with disease activity and bone destruction","volume":"192","author":"Xu","year":"2018","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.jneuroim.2022.577811_bb0145","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0955-0674(03)00107-8","article-title":"Synaptic adhesion molecules","volume":"15","author":"Yamagata","year":"2003","journal-title":"Curr. Opin. Cell Biol."},{"issue":"7","key":"10.1016\/j.jneuroim.2022.577811_bb0150","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1167\/iovs.10-6700","article-title":"TAM receptor knockout mice are susceptible to retinal autoimmune induction","volume":"52","author":"Ye","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.jneuroim.2022.577811_bb0155","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3390\/ijms22010118","article-title":"The gut-brain axis in autism spectrum disorder: a focus on the metalloproteases ADAM10 and ADAM17","volume":"22","author":"Zheng","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2022.577811_bb0160","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/431896","article-title":"The expression and clinical significance of different forms of Mer receptor tyrosine kinase in systemic lupus erythematosus","volume":"2014","author":"Zhu","year":"2014","journal-title":"J Immunol Res"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822000066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822000066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:40:19Z","timestamp":1759048819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572822000066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":32,"alternative-id":["S0165572822000066"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577811","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Up-regulated serum levels of TAM receptor tyrosine kinases in a group of Egyptian autistic children","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577811","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577811"}}